3rd Liquid Biopsy Surveillance Summit

The 3rd Liquid Biopsy Surveillance Summit covers topics such as:

• Advancing MRD Detection through Technological Innovation & Expanding Patient Access to Liquid Biopsies for Transformative Patient Surveillance
• Leveraging Liquid Biopsies to Optimize Patient Selection in Clinical Trials to Develop Safer & More Efficacious Drugs for Patients in Need
• Optimizing ctDNA Analysis for Tailored Dosage Regimens to Advance Precision in Clinical Decision-Making
• Harnessing MRD to Enhance Relapse Prediction & Strengthen Surveillance Strategies for Unprecedented Patient Care
• Redefining Patient Monitoring by Enhancing Surrogate Endpoints to Unlock Faster & More Comprehensive Clinical Insights
• Developing Collaborative Strategies to Enhance the Clinical Utility of Liquid Biopsies & Improve MRD Detection for Patient Monitoring
• Navigating Strategic Pathways to Reimbursement & Regulatory Success for Blood-Based Biomarkers in Oncology